Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Family criticizing your weight? You might add more pounds

  • Early exposure to antidepressants affects adult anxiety, serotonin transmission

  • Cocaine, amphetamine users more likely to take their own lives

  • New technology advances eye tracking as biomarker for brain function, recovery from brain injury

  • Tracking the eyes: The keys to consumers' plant preferences

  • Naming people, objects in baby's first year may offer learning benefits years later

  • Meth users face substantially higher risk for getting Parkinson's disease

  • First real-time mri-guided brain surgery for Parkinson's in southern California

  • How, where the brain converts external inputs into behavioral responses

  • Teen contraband smokers more likely to use illicit drugs: Study

  •